Free Trial

Kiora Pharmaceuticals (KPRX) SEC Filings & 10K Form

Kiora Pharmaceuticals logo
$3.08 +0.06 (+1.99%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$3.15 +0.07 (+2.27%)
As of 03/28/2025 05:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Kiora Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/25/2025
5:55 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/25/2025
5:57 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2025
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
10:39 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/10/2025
7:38 AM
HIRSCHMAN ORIN (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/15/2025
4:22 PM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:17 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Lind Global Fund II LP (Filed by)
Form SC 13G/A
11/14/2024
3:53 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SCHEDULE 13G
11/14/2024
3:32 PM
Alyeska Investment Group, L.P. (Filed by)
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Form SC 13G
11/13/2024
4:34 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Stonepine Capital Management, LLC (Filed by)
Form SC 13G/A
11/08/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
5:32 AM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
6:02 AM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
12:00 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:45 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:17 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
6:02 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
TYLE PRAVEEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
Hollander David (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Shapiro Aron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:15 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Parsons Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Stengone Carmine N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Walters-Hoffert Lisa (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
2:16 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Strem Brian M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:47 PM
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Tosca Melissa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
2:40 PM
Daniels Eric Joseph (Reporting)
KIORA PHARMACEUTICALS INC (Issuer)
Kiora Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:02 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
2:43 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G
05/29/2024
2:47 PM
KIORA PHARMACEUTICALS INC (Subject)
Kiora Pharmaceuticals (Subject)
Rosalind Advisors, Inc. (Filed by)
Form SC 13G
05/10/2024
5:59 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2024
6:00 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
6:01 AM
KIORA PHARMACEUTICALS INC (Filer)
Kiora Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:KPRX) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners